Status:
NOT_YET_RECRUITING
Belief-updating, Speech and Psychosis
Lead Sponsor:
King's College London
Conditions:
Psychosis
Eligibility:
All Genders
18-40 years
Brief Summary
Psychotic illnesses are characterised by hallucinations, delusions, and disturbed thoughts; symptoms associated with high personal and societal costs. Despite the efficacy of antipsychotic medication,...
Eligibility Criteria
Inclusion
- Inclusion criteria (FEP)
- Participants will be recruited from two routes:
- Participants who are part of Urban Mind study will be invited to the present study;
- Patients who are referred to the following early psychosis teams will also be invited to the study: Lambeth Early Psychosis (LEO), Southwark Team for Early Psychosis (STEP), Lewisham Early Intervention Service (LEIS), Croydon Outreach Assessment Support Team (COAST), Central and North West London NHS Foundation Trust (NWLFT).
- Participants from both routes will need to meet the following criteria:
- all participants are 18 to 40 years old
- all participants have an adequate command of the English language to complete the assessment
- all participants need access to laptop, smartphone or computer to complete the tasks
- all participants met FEP as defined by a DSM-IV diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder, or delusional disorder based on the Structured Clinical Interview for DSM-IV (SCID-I) (First et al., 2002).
Exclusion
- Exclusion criteria (FEP)
- Experienced more than one previous episode of psychosis
- Any other neurological disorders that could potentially interfere with study process or patients' safety
- Refusing to complete the belief-updating or speech tasks
- Participants' answers are identified as fake answers or participants complete the tasks for multiple times (identified by their unique participants code).
- Participants are unable to fully comprehend the purpose of the study or make a rational decision whether or not to participate
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2028
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06042712
Start Date
May 1 2024
End Date
April 30 2028
Last Update
March 6 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.